Avelos Therapeutics
PrivateLast Round
Series B
Apr 30, 2024
Total Funding Raised
$21.97M
Company Overview
Avelos Therapeutics operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in April 2024.
Avelos Therapeutics is a biotechnology company that specializes in the research and development of biomarker-driven, small molecule targeted therapies for cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avelos Therapeutics Comparables
Compare Avelos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Onconic Therapeutics | 82% | |
| Arum Therapeutics | 80% | |
| Il Dong Pharmaceutical Co Ltd | 79% |
For institutional investors. Book with your work email.
Avelos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 30, 2024 | ||||
| Series A | Jul 1, 2022 | ||||
| Seed | Feb 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avelos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series B, Series A |
| UTC Investment | Series A |
| Infobank Corp | Seed |
| QUAD Investment Management | Series B, Series A |
| STASSETS INVESTMENT | Series B |
| Timefolio Asset Management | Series A, Series B |
| Heungkuk Securities | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 77% MoM.
- Mar 2, 2026
Monthly visitors increased 114% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Avelos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avelos Therapeutics's valuation, stock price, and market status.
Is Avelos Therapeutics a public or private company?
Avelos Therapeutics is a private company.
What is the current stock price of Avelos Therapeutics?
Avelos Therapeutics is a private company, so its shares have no public market price. Caplight tracks Avelos Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avelos Therapeutics worth (valuation)?
Valuation information for Avelos Therapeutics is not publicly available.
Can I buy Avelos Therapeutics stock?
Avelos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avelos Therapeutics's last funding round?
Avelos Therapeutics's most recent funding round was Series B on April 30, 2024.
Who are the main investors in Avelos Therapeutics?
Key investors in Avelos Therapeutics include STASSETS INVESTMENT.
Will Avelos Therapeutics IPO soon?
No public IPO plans have been announced for Avelos Therapeutics.
How can I track Avelos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Avelos Therapeutics's shares on secondary markets.